Intellectual Property (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 27, 2014
Feb. 28, 2017
Feb. 29, 2016
Amortization expense   $ 63,579 $ 63,579
Research and development cost   $ 1,454,440 801,666
Description of royalty payments  

  (a) 10% of gross profits on the sale of all products derived by the Company from the technology assigned to the Company under the agreement;
     
  (b) 10% of any license fee paid to the Company in respect of any licensing or other right to use the technology assigned to the Company and granted to a third party by the Assignee;
     
  (c) 5% of any royalty or other similar payment made to the Company by a third party to whom a license or other right to use the technology assigned to the Company has been granted by the Company; and
     
  (d) 5% of any royalty or other similar payment made to the Company by a third party in respect of a sub-license or other right to use the technology assigned to the Company granted by the third party.

 
Intellectual Property, net of accumulated amortization   $ 137,050 $ 73,471
Mr. Hatem Essaddam [Member]      
Estimated Useful Life (Years) 7 years    
Research and development cost $ 445,050    
Description of milestone payments

  (i) CDN$200,000 when an average of twenty (20) metric tons per day of terephthalic acid is produced by the Company for twenty (20) operating days;
     
  (ii) CDN$200,000 when an average of thirty (30) metric tons per day of terephthalic acid is produced by the Company for thirty (30) operating days;
     
  (iii) CDN$200,000 when an average of sixty (60) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating days; and
     
  (iv) CDN$200,000 when an average of one hundred (100) metric tons per day of terephthalic acid is produced by the Company for sixty (60) operating days.